Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06377267
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-04-10
Brief Title:
Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab STROBE Trial
Sponsor:
Vall dHebron Institute of Oncology
Organization:
Vall dHebron Institute of Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-10
First Submit QC Date:
April 16 2024
Study First Post Date:
2024-04-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-08
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL